News & Updates

Show Multimedia Only

Prosthetic capsular bag shows potential in scleral fixation of IOL in eyes with no capsular support

06 Aug 2026

Researchers have developed a prosthetic capsular bag (PCB) for posterior scleral fixation of an intraocular lens (IOL) in eyes without capsular support, with a recent study demonstrating its viability.

Prosthetic capsular bag shows potential in scleral fixation of IOL in eyes with no capsular support

06 Aug 2026

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

06 Aug 2026 by

Adolescents with obesity who underwent bariatric surgery (BS) show substantial and sustained improvements in BMI and cardiometabolic health, according to a study.

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

06 Aug 2026

Older age, ocular hypertension predict glaucoma in eyes with PXF syndrome

06 Aug 2026

Perimetric glaucoma may develop in eyes with pseudoexfoliation syndrome (PXF) with or without ocular hypertension (OHTN), suggests a recent study. Factors such as older age, OHTN, higher cup-to-disc ratio (CDR), and phakia are associated with incident glaucoma.

Older age, ocular hypertension predict glaucoma in eyes with PXF syndrome

06 Aug 2026

Sustained smoking cessation protects against depression in COPD patients

06 Aug 2026

Sustained smoking cessation among patients with chronic obstructive pulmonary disease (COPD) has been linked to substantially reduced risk of subsequent depression, according to a study.

Sustained smoking cessation protects against depression in COPD patients

06 Aug 2026

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

06 Aug 2026 by

Treatment with mezigdomide (Mezi) plus carfilzomib and dexamethasone (Kd) significantly improves progression-free survival (PFS) in patients with relapsed or refractory multiple myeloma (RRMM) compared with Kd regimen only, according to the phase III SUCCESSOR-2 trial presented at EHA 2026.

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

06 Aug 2026

Protection from birth: Translating maternal RSV immunisation into clinical practice

06 Aug 2026

Professor Dr Raman Subramaniam and Dato’ Dr Musa Mohd Nordin give their insights on respiratory syncytial virus (RSV) from obstetrics and gynaecology and paediatric perspectives, respectively. Here, they highlight how maternal RSV immunisation may help address an important gap in infant protection while raising important considerations regarding implementation, education, and access. RSV is a major cause of acute lower respiratory tract infection in infants and young children worldwide. Most infections are self-limiting, but RSV can cause severe bronchiolitis, pneumonia, hospitalization even death, especially in the first months of life. As awareness of RSV increases, and with preventive options becoming available, maternal immunisation is emerging as a viable strategy to protect infants during their most vulnerable stage.

Protection from birth: Translating maternal RSV immunisation into clinical practice

06 Aug 2026

Cannabinoid combination quells agitation in late-stage dementia patients

05 Aug 2026 by

The experimental combination of tetrahydrocannabinol (THC) plus cannabidiol (CBD) proves beneficial in reducing agitation in hospice care-eligible patients with late-stage dementia, according to the phase II LiBBY trial.

Cannabinoid combination quells agitation in late-stage dementia patients

05 Aug 2026

Ageing population drives healthcare expenditure in SG

05 Aug 2026 by

An ageing population and increasing clinical complexity are both propelling the rise in expenditure and utilization of healthcare in Singapore, a study has found.

Ageing population drives healthcare expenditure in SG

05 Aug 2026

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

05 Aug 2026 by

Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

05 Aug 2026

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients

05 Aug 2026

Treatment with standard ceftriaxone dose delivers adequate target attainment at low minimum inhibitory concentrations (MICs) in hospitalized patients with suspected sepsis, according to a Thai study.

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients

05 Aug 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Prosthetic capsular bag shows potential in scleral fixation of IOL in eyes with no capsular support

Prosthetic capsular bag shows potential in scleral fixation of IOL in eyes with no capsular support

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

Older age, ocular hypertension predict glaucoma in eyes with PXF syndrome

Older age, ocular hypertension predict glaucoma in eyes with PXF syndrome

Sustained smoking cessation protects against depression in COPD patients

Sustained smoking cessation protects against depression in COPD patients

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

Protection from birth: Translating maternal RSV immunisation into clinical practice

Protection from birth: Translating maternal RSV immunisation into clinical practice

Cannabinoid combination quells agitation in late-stage dementia patients

Cannabinoid combination quells agitation in late-stage dementia patients

Ageing population drives healthcare expenditure in SG

Ageing population drives healthcare expenditure in SG

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients